Navigation Links
Dr. Kenneth Pettine Introduces Treatment of Inflammation of Osteoarthritic Knees with Mesenchymal Stem Cells
Date:1/30/2017

Dr. Kenneth Pettine is proud to introduce the use of Mesenchymal Stem Cells for the treatment of inflammation of osteoarthritic knees. It is estimated that osteoarthritis (“OA”) affects about 50 million Americans. Osteoarthritis is a process that can occur in any joint where the articular cartilage diminishes in thickness as one ages. This process continues throughout one’s life until all the articular cartilage is gone.

Thereafter, in the case of osteoarthritic knee joints, weight applied on the knee results in bone on bone wear. In most cases this process is associated with gradual, increasing pain, to the point that any walking can be unbearable. Osteoarthritis of the knee may also be associated with night pain that can severely inhibit a normal sleep pattern.

Osteoarthritis of the knee is an almost ubiquitous condition in humans over the age of 60. Osteoarthritis of the knee does typically affect the medial tibiofemoral joint. Many people develop gradual degradation of the articular cartilage on the medial aspect of their knee, which results in their knees becoming progressively bowlegged or genu varum. Often the pain of the arthritis is felt along the medial side of the knee and specifically the proximal tibial plateau. MRI scanning often shows a hyperemic area just beneath the medial part of the knee joint in the metaphysis of the tibia. The knee joint consists of the medial and lateral femoral tibial compartments and the patella-femoral joint. Osteoarthritis can primarily impact any one of these areas or all three. It is known that the most common type is osteoarthritis of the medial tibial femoral joint.

Currently, The American Academy of Orthopedic Surgeons (“AAOS”) recommended treatments for osteoarthritis of the knee include the following: weight loss, gentle exercise, anti-inflammatory medications followed by total knee replacement. The AAOS does not recommend arthroscopic debridement or any hyaluronic acid products such as SYNVISC®, EUFLEXXA™, ORTHOVISC®, SUPARTZ™, or HYALGAN® for treating knee osteoarthritis.

Last year in the United States over one and a half million total hip and knee replacements were performed with a direct cost of over $40 billion. These numbers are expected to double in the next three years. Additionally, it has been reported that every day 10,000 people in the United States turn 65 years of age, and that this will continue for the next 14 years. Imagine every week there is a football stadium full of brand new 65 year olds!

Mesenchymal stem cells (MSCs), after their initial discovery in bone marrow, have been isolated and characterized from several adult and fetal tissues, including adipose (fat), dermis (skin), synovial fluid, periosteum, umbilical cord blood, placenta and amniotic fluid. MSCs are partially defined by their ability to differentiate into tissues including osteoblasts (bone cells), chondrocytes (cartilage cells), myocytes (muscle cells), and adipocytes (fat cells). It is believed that it is their trophic, paracrine and immunomodulatory functions that may have the greatest therapeutic impact in vivo. Unlike pharmaceutical treatments that deliver a single agent at a specific dose, MSCs are site regulated and secrete bioactive factors and signals at variable concentrations in response to local microenvironmental cues.

Treating inflammation associated with osteoarthritis of the knee joint by using MSCs is done by injecting the cells into the symptomatic knee. In one aspect, the mesenchymal stem cells may be obtained autogenously. In another aspect, the osteoarthritis may be located in the medial tibial femoral joint of the knee. In yet another aspect, the mesenchymal stem cells are injected below the medial tibial plateau of the knee joint, resulting in alleviation of the symptoms of the osteoarthritis.MC

For more information about Dr. Kenneth Pettine, MSC therapy for the treatment of inflammation due to osteoarthritis, and other MCC therapy treatment options, visit http://kennethpettine.com/

Read the full story at http://www.prweb.com/releases/2017/02/prweb14025808.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related medicine news :

1. Delta Dental Hires Dr. Kenneth Yale as Senior Vice President and Chief Clinical Officer
2. Dr. Kenneth Peavy Now Accepts New Gum Disease Patients From Greensboro, NC for Laser Treatment
3. Dr. Kenneth Nash Opens Doors to Patients with Missing Teeth in Vicksburg, MS for Permanent Tooth Replacement Procedures
4. In Recognition of National Diabetes Month, Dr. Kenneth A. Peavy Educates Patients on the Relationship Between Diabetes and Gum Disease in Winston Salem, NC
5. Kenneth Coombs Releases The Complete Dictionary of Tarot Card Combinations, First in History
6. Kenneth N. Parson Discusses Laboratory Management
7. Kenneth D. Barringer’s New Book Helps Retirees Live Wellness Lifestyle
8. Arcadia Dentist Dr. Kenneth J. Canzoneri Announces New Treatment with High-Tech Dental Laser Making No Shot, No Drill, No Pain Dentistry Possible
9. Mount Sinai CEO Kenneth L. Davis, MD: Our Ability to Access Information in Real Time to Prevent Disease is Drawing Closer
10. Kenneth D. Barringer Guides Readers to Healthy Retirement with New Book
11. Mount Sinai CEO Kenneth L. Davis, MD, Featured at 2015 Aspen Ideas Festival
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... ... As health professionals work to improve their approach to healthcare, there is a ... filling out a survey; in many cases health professionals and patients are working together ... research on the importance of active engagement with patients and members of the public ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical associate professor ... prevention of cardiovascular diseases during the 15th Annual Women’s Health Conference. The ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... products to meet the demand of today’s consumer and regulatory authorities worldwide. From ... probiotic experts and tested to meet the highest standard. , These products ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... 10, 2017   West Pharmaceutical Services, Inc. ... injectable drug administration, today shared the results of a ... improving the intradermal administration of polio vaccines. The study ... in May 2017 by Dr. Ondrej Mach , ... Health Organization (WHO), and recently published in the journal ...
(Date:10/4/2017)... Korea , Oct. 4, 2017  South Korean-based ... next-generation CPR training aide "cprCUBE" on Kickstarter. The device ... compression during cardiac arrests with better efficiency compared to ... also offers real-time feedback on efficacy of the compression ... crowdfunding campaign has a goal to raise $5,000. ...
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
Breaking Medicine Technology: